NLRP3 Inflammasome Expression and Signaling in Human Diabetic Wounds and in High Glucose Induced Macrophages
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
NLRP3 Inflammasome Expression and Signaling in Human Diabetic Wounds and in High Glucose Induced Macrophages
Authors
Keywords
-
Journal
Journal of Diabetes Research
Volume 2017, Issue -, Pages 1-7
Publisher
Hindawi Limited
Online
2017-01-11
DOI
10.1155/2017/5281358
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- High Glucose and Lipopolysaccharide Prime NLRP3 Inflammasome via ROS/TXNIP Pathway in Mesangial Cells
- (2016) Hong Feng et al. Journal of Diabetes Research
- Role of the NLRP3 inflammasome in the transient release of IL-1β induced by monosodium urate crystals in human fibroblast-like synoviocytes
- (2015) Shu-cong Zheng et al. Journal of Inflammation-London
- Mangiferin inhibits endoplasmic reticulum stress-associated thioredoxin-interacting protein/NLRP3 inflammasome activation with regulation of AMPK in endothelial cells
- (2015) Junna Song et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- NLRP3Inflammasome Polymorphism and Macrovascular Complications in Type 2 Diabetes Patients
- (2015) Jasna Klen et al. Journal of Diabetes Research
- Nod-Like Receptor Protein-3 Inflammasome Plays an Important Role during Early Stages of Wound Healing
- (2015) Eileen M. Weinheimer-Haus et al. PLoS One
- The Role of Macrophage Polarization in Infectious and Inflammatory Diseases
- (2014) Adam C. Labonte et al. MOLECULES AND CELLS
- Inhibition of inflammasome activation improves the impaired pattern of healing in genetically diabetic mice
- (2013) Alessandra Bitto et al. BRITISH JOURNAL OF PHARMACOLOGY
- Rosuvastatin Alleviates Diabetic Cardiomyopathy by Inhibiting NLRP3 Inflammasome and MAPK Pathways in a Type 2 Diabetes Rat Model
- (2013) Beibei Luo et al. CARDIOVASCULAR DRUGS AND THERAPY
- Sustained Inflammasome Activity in Macrophages Impairs Wound Healing in Type 2 Diabetic Humans and Mice
- (2013) R. E. Mirza et al. DIABETES
- Blocking Interleukin-1 Induces a Healing-Associated Wound Macrophage Phenotype and Improves Healing in Type 2 Diabetes
- (2013) R. E. Mirza et al. DIABETES
- NLRP3 and IL-1βin macrophages as critical regulators of metabolic diseases
- (2013) A. F. McGettrick et al. DIABETES OBESITY & METABOLISM
- Enhancer of Zeste Homolog 2 Is a Negative Regulator of Mitochondria-Mediated Innate Immune Responses
- (2013) S. Chen et al. JOURNAL OF IMMUNOLOGY
- NLRP3 Inflammasome and Host Protection against Bacterial Infection
- (2013) Jwa-Jin Kim et al. JOURNAL OF KOREAN MEDICAL SCIENCE
- Activation of the Nlrp3 inflammasome in infiltrating macrophages by endocannabinoids mediates beta cell loss in type 2 diabetes
- (2013) Tony Jourdan et al. NATURE MEDICINE
- Dipeptidyl Peptidase 4 Inhibition May Facilitate Healing of Chronic Foot Ulcers in Patients with Type 2 Diabetes
- (2012) Raffaele Marfella et al. Experimental Diabetes Research
- Metabolic Syndrome: Is Nlrp3 Inflammasome a Trigger or a Target of Insulin Resistance?
- (2011) Marcelo A. Mori et al. CIRCULATION RESEARCH
- Impaired TGF-β signaling and a defect in resolution of inflammation contribute to delayed wound healing in a female rat model of type 2 diabetes
- (2011) Fahd Al-Mulla et al. Molecular BioSystems
- Biglycan, a Danger Signal That Activates the NLRP3 Inflammasome via Toll-like and P2X Receptors
- (2009) Andrea Babelova et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started